Delivery Order SPE2DB25D3504-SPE2DB26FVTJV
- Not listed
- The Defense Logistics Agency awarded a $2,841.36 delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Gabapentin 600 mg tablets in quantities of 500 units. This firm fixed-price contract, with a completion date of July 11, 2025, is classified as a child contract and represents a non-competitive set-aside award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and primary pharmaceutical distributor for this delivery. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 tablets of Gabapentin 600 mg, with a firm fixed price ceiling value of $1,294.68. The order was issued on September 26, 2025, with an ultimate completion date of September 29, 2025. This non-competitive delivery order represents pharmaceutical procurement from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary distribution...
- The Defense Logistics Agency awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of 1,000 units of Gabapentin 300 mg capsules at a ceiling value of $1,982.22. This non-set-aside competitive award is scheduled for completion by October 30, 2025, with performance fulfilled from the contractor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $2,858.01 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of 500 tablets of Gabapentin 800 mg. This is a firm fixed-price, non-set-aside contract with a completion date of July 23, 2025, and performance at the vendor's Conshohocken, Pennsylvania facility. The delivery order represents a small-value pharmaceutical procurement supporting federal medical supply requirements, consistent with routine military healthcare operations....
- This is a firm fixed-price delivery order worth $2,362.56 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of gabapentin 600 mg tablets. The order has a completion date of September 11, 2024. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which serves as a primary vehicle for providing a wide range of...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at two hundred seven dollars and forty-five cents to Amerisourcebergen Drug Corporation for gabapentin tablets. As the prime contractor, Amerisourcebergen will supply ninety tablets of six-hundred milligram gabapentin to fulfill requirements under the order. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one-day period concluding on September 29, 2023. The Defense...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,924,465 Gabapentin 800 mg tablets. The firm-fixed price contract, with a ceiling value of $1,923.48, has an ultimate completion date of September 25, 2024. AmerisourceBergen, a major pharmaceutical distributor, is supplying these prescription medications to support military treatment facilities and other federal healthcare providers. The contract is not designated as a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Gabapentin 800 mg tablets. The contract, valued at $2,016.96, is a Delivery Order issued by the Defense Logistics Agency (DLA) and has an ultimate completion date of December 30, 2024. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite...
- The Defense Logistics Agency Troop Support Medical awarded a $580,210 firm fixed price delivery order to Amerisourcebergen Drug Corporation for gabapentin capsules. The delivery order was issued against an indefinite-delivery/indefinite-quantity contract vehicle and calls for Amerisourcebergen to supply 456,163,805 gabapentin capsules to DLA from its facility in Conshohocken, Pennsylvania. Performance is required between July 26 and September 2, 2023. As the DLA is the logistics combat support...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $81,360 to Amerisourcebergen Drug Corporation to supply 4561708864 gabapentin 800 mg tablets. Under the terms of the order, Amerisourcebergen will deliver 90 tablets to a facility in Conshohocken, Pennsylvania, with performance spanning from August 4 through August 7, 2023. As a major distributor of pharmaceuticals and medical supplies for the Department of Defense, Amerisourcebergen frequently supports DLA's...
- SPE2DB25D3504Indefinite Delivery Contract
- SPE2DB25D3504-SPE2DB26FVTJVDelivery Order
The Defense Logistics Agency awarded a $1,153.82 delivery order to AmerisourceBergen Drug Corp for the supply of Gabapentin 800 mg tablets (500-count units) with an ultimate completion date of November 3, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is performing this work at its corporate office location. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. The delivery order supports federal medical procurement needs for the Defense Logistics Agency's Medical Supply Chain, which serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Gabapentin is a neurological treatment commonly used in military and veteran healthcare settings. AmerisourceBergen's established relationship with DLA, demonstrated through its substantial prime IDC and consistent track record of competitive awards for diverse pharmaceutical products, positions the company as a critical vendor for federal medical supply needs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 10/31/25 |